Willis Towers Watson Public Limited Company's Stock Analysis

Willis Towers Watson Shareholder Meeting Approves Key Proposals

On May 20, 2026, Willis Towers Watson held its Annual General Meeting of Shareholders, where 92.8% of outstanding ordinary shares were represented. Shareholders approved all proposals, including the election of directors, the appointment of Deloitte & Touche LLP as auditors, and the advisory approval of executive compensation. Additionally, the renewal of the Board's authority to issue shares and opt out of statutory pre-emption rights was also ratified.

The shareholders further approved the Amended and Restated Employee Share Purchase Plan, which includes an increase in the number of shares authorized for issuance. The voting results indicated significant support for these measures, with the majority of votes cast in favor of the proposals, reflecting shareholder alignment on the company's governance and compensation practices.

May 21, 2026 16:53:57

Willis Towers Watson Reports First Quarter 2026 Financial Results

Willis Towers Watson Public Limited Company reported revenue of $2.41 billion for the first quarter of 2026, an 8% increase from the previous year. Organic revenue growth was 3%, with net income rising to $303 million, compared to $239 million in the prior-year quarter. Diluted earnings per share increased by 33% to $3.10, while adjusted diluted earnings per share rose 19% to $3.72. The operating margin was 18.6%, a decrease of 80 basis points, but the adjusted operating margin improved to 22.3%, up 70 basis points from the previous year.

In terms of segment performance, the Health, Wealth & Career segment generated $1.27 billion in revenue, marking a 9% increase, while the Risk & Broking segment also saw a 9% revenue rise to $1.12 billion. The company repurchased $300 million of its shares during the quarter. Cash flows used in operating activities were $10 million, an improvement from $35 million used in the prior year, and free cash flow also showed improvement, narrowing from $(86) million to $(65) million. The company anticipates continued margin expansion and plans for share repurchases of $1 billion or more, subject to market conditions.

Apr 30, 2026 06:02:20

Willis Towers Watson Reports Fourth Quarter and Full Year Results

Willis Towers Watson announced its financial results for the fourth quarter and full year ended December 31, 2025, reporting a revenue of $2.94 billion for the quarter, a decrease of 3% compared to the same period in the prior year, and a total revenue of $9.71 billion for the year, down 2%. Organic revenue growth was reported at 6% for the quarter and 5% for the year. The company reported a net income of $736 million for the fourth quarter, down from $1.25 billion in the prior-year quarter, while the full year saw a net income of $1.61 billion, a recovery from a net loss of $88 million the previous year. Adjusted diluted earnings per share were $8.12 for the quarter and $17.08 for the year, reflecting increases of 2% and 5%, respectively, from the prior year.

The company highlighted strong performance in its Health, Wealth & Career segment, despite an 11% revenue decline attributed to the sale of TRANZACT. This segment achieved organic revenue growth of 6%. The Risk & Broking segment experienced a 10% increase in revenue, driven by new business activity and client retention. For the year, cash flows from operating activities were $1.78 billion, an increase from $1.51 billion the prior year, and free cash flow improved to $1.55 billion. The company repurchased $350 million in shares during the fourth quarter and $1.65 billion for the entire year, reflecting its commitment to returning capital to shareholders.

Feb 03, 2026 06:02:33

Willis Towers Watson Completes Acquisition of Newfront Insurance Holdings

Willis Towers Watson Public Limited Company has finalized its acquisition of Newfront Insurance Holdings, Inc. This acquisition aims to enhance WTW's capabilities in the U.S. middle market and strengthen its position in high-growth sectors such as technology and life sciences. Newfront, based in San Francisco, brings a technology-driven broking model and expertise in various industries, which WTW plans to integrate into its existing operations.

The integration of Newfront will allow WTW to offer improved services to clients by leveraging Newfront's advanced technology and specialized knowledge. Newfront's major business segments will now be part of WTW's existing Risk & Broking and Health, Wealth & Career segments, enhancing the company's ability to serve clients efficiently. The transaction is expected to contribute to WTW's strategic goals and long-term value creation for stakeholders.

Jan 27, 2026 12:43:07

Willis Towers Watson Secures $775 Million Loan Facility

Willis Towers Watson Public Limited Company, along with its subsidiary Trinity Acquisition plc and subsidiary Willis North America Inc., has entered into a $775 million delayed draw term loan facility. This facility will mature either three years after the initial borrowing or three years after a specified acquisition date related to Newfront Insurance Holdings, Inc. The funds will be utilized for financing the Newfront acquisition, refinancing existing debt, and for other corporate purposes.

The loan will accrue interest based on either the Term SOFR rate or the base rate, with specific margins dependent on the company’s debt rating. The facility allows for multiple borrowings, subject to customary conditions, and includes various covenants and reporting obligations for WTW and its subsidiaries. The obligations under the facility are guaranteed by WTW and certain subsidiaries, and the loan is unsecured.

Jan 09, 2026 16:32:55

Willis Towers Watson Issues $1 Billion in Senior Notes

On December 22, 2025, Willis North America Inc. completed an offering of $700 million in 4.550% Senior Notes due 2031 and $300 million in 5.150% Senior Notes due 2036. These notes are fully guaranteed by Willis Towers Watson Public Limited Company and other affiliated entities. The notes will accrue interest starting December 22, 2025, with payments scheduled for March 15 and September 15 each year, beginning September 15, 2026. The offering was made under a public registration statement and the notes rank equally with the issuer's existing senior unsecured debt.

The net proceeds from the offering are approximately $990 million. If the Newfront acquisition closes, the proceeds will be used for the acquisition costs and to repay $550 million of existing senior notes due 2026. If the acquisition does not close, the proceeds will still be used to repay the 2026 notes and redeem the 2036 notes. Any remaining funds will be allocated for general corporate purposes.

Dec 22, 2025 16:43:02

Willis Towers Watson Prices $1 Billion Senior Notes Offering

Willis Towers Watson Public Limited Company announced the pricing of a $1 billion offering of senior notes, which includes $700 million of 4.550% senior notes due 2031 and $300 million of 5.150% senior notes due 2036. The offering is set to close on December 22, 2025, and the notes will be fully guaranteed by the company and certain subsidiaries. The net proceeds from the offering are expected to be approximately $990 million after expenses.

The proceeds from the offering will primarily be used to finance the Newfront acquisition and to repay $550 million of 4.400% senior notes due 2026. If the acquisition does not close, the funds will still be allocated to repay the 4.400% senior notes and to redeem the 2036 notes. Any remaining proceeds will be directed towards general corporate purposes. The offering is not contingent on the Newfront acquisition closing.

Dec 16, 2025 17:30:22

Willis Towers Watson to Acquire Newfront for $1.3 Billion

Willis Towers Watson has signed an agreement to acquire Newfront Insurance Holdings for a total consideration of $1.3 billion, which includes $1.05 billion upfront and up to $250 million in contingent payments based on performance targets. The transaction has been approved by the Company's Board of Directors and is anticipated to close in the first quarter of 2026, pending regulatory approvals. This acquisition aims to enhance WTW's presence in the U.S. middle market and expand its capabilities in high-growth sectors such as technology and life sciences.

The integration of Newfront is expected to yield significant synergies, with projected cost savings of approximately $35 million by the end of 2028. The upfront payment consists of about $900 million in cash and $150 million in equity for Newfront's employee-shareholders. WTW will also provide retention incentives totaling $100 million for Newfront employees through 2031. The transaction is projected to be dilutive to Adjusted EPS in 2026 but accretive in 2027, reflecting a strategic move to leverage Newfront's technology and expertise.

Dec 10, 2025 06:42:25

Willis Towers Watson Reports Third Quarter 2025 Financial Results

Willis Towers Watson (WTW) announced its financial results for the third quarter of 2025, reporting revenue of $2.29 billion, which remained flat compared to the same period last year due to the sale of its TRANZACT business. Organic revenue grew by 5%, while net income for the quarter was $306 million, a significant recovery from a net loss of $1.67 billion in the prior year. Adjusted diluted earnings per share rose to $3.07, reflecting an 11% increase from the previous year, and operating margins improved to 20.4%, up 230 basis points year-over-year, indicating enhanced operational efficiency despite external challenges.

The company also highlighted its cash flow performance, with operating cash flows reaching $1 billion for the nine months ended September 30, 2025, compared to $913 million for the same period in 2024. Free cash flow increased to $838 million, primarily driven by operating margin expansion. WTW repurchased approximately 1.85 million shares for $600 million during the quarter and plans to continue share repurchases of around $1.5 billion, subject to market conditions. The company expects foreign currency fluctuations to positively impact adjusted diluted earnings per share in the fourth quarter.

Oct 30, 2025 06:03:35

Willis Towers Watson Secures $1.5 Billion Credit Facility

Willis Towers Watson Public Limited Company, along with its subsidiaries, has established a $1.5 billion revolving credit facility that is set to mature on October 17, 2030. The facility is intended to refinance existing obligations and will support working capital, capital expenditures, acquisitions, and other corporate purposes. Interest rates on the loans will vary based on WTW's credit rating and can be based on different benchmarks.

The credit facility imposes various covenants and conditions, including limitations on additional indebtedness and requirements for financial reporting. The obligations are guaranteed by WTW and certain subsidiaries, and the facility is unsecured. There are provisions for voluntary and mandatory prepayments, as well as events of default that could impact WTW's financial standing.

Oct 20, 2025 16:30:46